BALTIMORE--(BUSINESS WIRE)--Longeviti Neuro Solutions today announced a new 510(k) clearance by the U.S Food and Drug Administration (FDA) for the ClearFit ® implant that acknowledges the use of ...
This specific cranial implant allocates unprecedented access into the brain allowing physicians to see into the brain real-time, reduce patient radiation exposure, allow point of access care so ...
Please provide your email address to receive an email when new articles are posted on . A Maryland-based neurotechnology company has secured a U.S. patent for its novel prosthetic translucent, cranial ...
Longeviti Neuro Solutions LLC has received the U.S. FDA’s nod for use of its Clearfit cranial implant with postoperative ultrasound imaging. The expanded 510(k) clearance could help in reducing ...
Longeviti Neuro Solutions LLC has received the U.S. FDA’s nod for use of its Clearfit cranial implant with postoperative ultrasound imaging. The expanded 510(k) clearance could help in reducing ...